{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:57:55Z","timestamp":1760122675207},"reference-count":42,"publisher":"Elsevier BV","issue":"31","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Queensland Government Smart State National and International Research Alliances Program"},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["553055","1049571"],"award-info":[{"award-number":["553055","1049571"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Michael Smith Foundation Post-Doctoral Fellowship"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.vaccine.2017.05.063","type":"journal-article","created":{"date-parts":[[2017,6,8]],"date-time":"2017-06-08T19:15:17Z","timestamp":1496949317000},"page":"3883-3888","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Multistage vaccines containing outer membrane, type III secretion system and inclusion membrane proteins protects against a Chlamydia genital tract infection and pathology"],"prefix":"10.1016","volume":"35","author":[{"given":"Connor P.","family":"O'Meara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles W.","family":"Armitage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean W.","family":"Andrew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avinash","family":"Kollipara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nils Y.","family":"Lycke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew A.","family":"Potter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volker","family":"Gerdts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolai","family":"Petrovsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth W.","family":"Beagley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.05.063_b0005","series-title":"International handbook of chlamydia","author":"Patel","year":"2008"},{"key":"10.1016\/j.vaccine.2017.05.063_b0010","series-title":"Chlamydia trachomatis infections of the adult","author":"Stamm","year":"1990"},{"key":"10.1016\/j.vaccine.2017.05.063_b0015","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1086\/598983","article-title":"Modeling the impact of potential vaccines on epidemics of sexually transmitted chlamydia trachomatis infection","volume":"199","author":"Gray","year":"2009","journal-title":"J Infect Dis."},{"key":"10.1016\/j.vaccine.2017.05.063_b0020","doi-asserted-by":"crossref","first-page":"8478","DOI":"10.1073\/pnas.1331135100","article-title":"Genomic transcriptional profiling of the developmental cycle of Chlamydia trachomatis","volume":"100","author":"Belland","year":"2003","journal-title":"Proc Natl Acad Sci USA."},{"key":"10.1016\/j.vaccine.2017.05.063_b0025","doi-asserted-by":"crossref","first-page":"e568","DOI":"10.1371\/journal.pone.0000568","article-title":"Expression, processing, and localization of PmpD of Chlamydia trachomatis Serovar L2 during the chlamydial developmental cycle","volume":"2","author":"Kiselev","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2017.05.063_b0030","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1128\/IAI.72.4.1843-1855.2004","article-title":"Chlamydial persistence: beyond the biphasic paradigm","volume":"72","author":"Hogan","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.05.063_b0035","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/j.1462-5822.2011.01598.x","article-title":"Altered developmental expression of polymorphic membrane proteins in penicillin-stressed Chlamydia trachomatis","volume":"13","author":"Carrasco","year":"2011","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.vaccine.2017.05.063_b0040","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1517\/17425247.2.3.549","article-title":"Delivery of Chlamydia vaccines","volume":"2","author":"Igietseme","year":"2005","journal-title":"Expert Opin Drug Deliv."},{"key":"10.1016\/j.vaccine.2017.05.063_b0045","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1128\/IAI.00881-10","article-title":"Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model","volume":"79","author":"Farris","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.05.063_b0050","doi-asserted-by":"crossref","first-page":"396","DOI":"10.2174\/15665240113136660078","article-title":"The mouse model of Chlamydia genital tract infection: a review of infection, disease, immunity and vaccine development","volume":"14","author":"O'Meara","year":"2013","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.vaccine.2017.05.063_b0055","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fmicb.2010.00114","article-title":"The Chlamydial Type III secretion mechanism: revealing cracks in a tough nut","volume":"1","author":"Betts-Hampikian","year":"2010","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2017.05.063_b0060","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1517\/17460441.2015.1019860","article-title":"Approaches targeting the type III secretion system to treat or prevent bacterial infections","volume":"10","author":"Charro","year":"2015","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.vaccine.2017.05.063_b0065","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1146\/annurev.cellbio.18.012502.105845","article-title":"The chlamydial inclusion: escape from the endocytic pathway","volume":"18","author":"Fields","year":"2002","journal-title":"Annual review of cell and developmental biology."},{"key":"10.1016\/j.vaccine.2017.05.063_b0070","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1462-5822.1999.00012.x","article-title":"The Chlamydia trachomatis IncA protein is required for homotypic vesicle fusion","volume":"1","author":"Hackstadt","year":"1999","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.vaccine.2017.05.063_b0075","doi-asserted-by":"crossref","first-page":"e1000022","DOI":"10.1371\/journal.ppat.1000022","article-title":"SNARE protein mimicry by an intracellular bacterium","volume":"4","author":"Delevoye","year":"2008","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2017.05.063_b0080","doi-asserted-by":"crossref","first-page":"5362","DOI":"10.1128\/IAI.00539-06","article-title":"The GTPase Rab4 interacts with Chlamydia trachomatis inclusion membrane protein CT229","volume":"74","author":"Rzomp","year":"2006","journal-title":"Infect Immun."},{"key":"10.1016\/j.vaccine.2017.05.063_b0085","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1099\/jmm.0.040857-0","article-title":"ISCOMATRIX: a novel adjuvant for use in prophylactic and therapeutic vaccines against infectious diseases","volume":"61","author":"Morelli","year":"2012","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2017.05.063_b0090","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.4049\/jimmunol.158.8.3936","article-title":"Genetically engineered nontoxic vaccine adjuvant that combines B cell targeting with immunomodulation by cholera toxin A1 subunit","volume":"158","author":"Agren","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.05.063_b0095","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.4049\/jimmunol.162.4.2432","article-title":"Adjuvanticity of the cholera toxin A1-based gene fusion protein, CTA1-DD, is critically dependent on the ADP-ribosyltransferase and Ig-binding activity","volume":"162","author":"Agren","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.05.063_b0100","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.4049\/jimmunol.1002881","article-title":"A unique role of the cholera toxin A1-DD adjuvant for long-term plasma and memory B cell development","volume":"186","author":"Bemark","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.05.063_b0105","doi-asserted-by":"crossref","first-page":"6540","DOI":"10.1016\/j.vaccine.2011.07.009","article-title":"Immunization with PCEP microparticles containing pertussis toxoid, CpG ODN and a synthetic innate defense regulator peptide induces protective immunity against pertussis","volume":"29","author":"Garlapati","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.05.063_b0110","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.1016\/j.vaccine.2012.06.021","article-title":"Advax, a polysaccharide adjuvant derived from delta inulin, provides improved influenza vaccine protection through broad-based enhancement of adaptive immune responses","volume":"30","author":"Honda-Okubo","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.05.063_b0115","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1128\/IAI.31.3.1161-1176.1981","article-title":"Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis","volume":"31","author":"Caldwell","year":"1981","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.05.063_b0120","doi-asserted-by":"crossref","first-page":"11143","DOI":"10.1073\/pnas.93.20.11143","article-title":"A recombinant Chlamydia trachomatis major outer membrane protein binds to heparan sulfate receptors on epithelial cells","volume":"93","author":"Su","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2017.05.063_b0125","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4049\/jimmunol.182.3.1602","article-title":"Novel Chlamydia muridarum T cell antigens induce protective immunity against lung and genital tract infection in murine models","volume":"182","author":"Yu","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2017.05.063_b0130","doi-asserted-by":"crossref","first-page":"e61962","DOI":"10.1371\/journal.pone.0061962","article-title":"Immunization with a MOMP-Based Vaccine Protects Mice against a Pulmonary Chlamydia Challenge and Identifies a disconnection between infection and pathology","volume":"8","author":"O'Meara","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2017.05.063_b0135","series-title":"High throughput protein expression and purification: methods and protocols","author":"Doyle","year":"2009"},{"key":"10.1016\/j.vaccine.2017.05.063_b0140","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1099\/vir.0.058461-0","article-title":"Induction of mucosal immunity and protection by intranasal immunization with a respiratory syncytial virus subunit vaccine formulation","volume":"95","author":"Garg","year":"2014","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2017.05.063_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2014.09.034","article-title":"Immunogenicity and safety of Advax, a novel polysaccharide adjuvant based on delta inulin, when formulated with hepatitis B surface antigen: a randomized controlled Phase 1 study","author":"Gordon","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.05.063_b0150","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1128\/IAI.64.9.3833-3844.1996","article-title":"NYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria","volume":"64","author":"Tine","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.05.063_b0155","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1086\/515331","article-title":"Phase I\/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria","volume":"177","author":"Ockenhouse","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2017.05.063_b0160","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1172\/JCI46252","article-title":"The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection","volume":"122","author":"Lin","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2017.05.063_b0165","doi-asserted-by":"crossref","DOI":"10.1111\/2049-632X.12203","article-title":"Target cell limitation constrains chlamydial load in persistent infections: results from mathematical modelling applied to mouse genital tract infection data","author":"Craig","year":"2014","journal-title":"Pathog Dis"},{"key":"10.1016\/j.vaccine.2017.05.063_b0170","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1128\/AAC.02097-13","article-title":"Induction of the Chlamydia muridarum stress\/persistence response increases azithromycin treatment failure in a murine model of infection","volume":"58","author":"Phillips-Campbell","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2017.05.063_b0175","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nri3251","article-title":"Recent progress in mucosal vaccine development: potential and limitations","volume":"12","author":"Lycke","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2017.05.063_b0180","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1016\/j.vaccine.2014.06.002","article-title":"Evaluation of a multisubunit recombinant polymorphic membrane protein and major outer membrane protein T cell vaccine against Chlamydia muridarum genital infection in three strains of mice","volume":"32","author":"Yu","year":"2014","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2017.05.063_b0185","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.06338-11","article-title":"Chlamydia muridarum T cell antigens and adjuvants that induce protective immunity in mice","author":"Yu","year":"2012","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2017.05.063_b0190","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1574-695X.2008.00527.x","article-title":"Identification and characterization of novel recombinant vaccine antigens for immunization against genital Chlamydia trachomatis","volume":"55","author":"Coler","year":"2009","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2017.05.063_b0195","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1128\/CVI.00274-07","article-title":"Induction of cross-serovar protection against genital chlamydial infection by a targeted multisubunit vaccination approach","volume":"14","author":"Li","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2017.05.063_b0200","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/icb.2013.92","article-title":"Immunity against a Chlamydia infection and disease may be determined by a balance of IL-17 signaling","volume":"92","author":"O'Meara","year":"2013","journal-title":"Immunol Cell Biol."},{"key":"10.1016\/j.vaccine.2017.05.063_b0205","doi-asserted-by":"crossref","unstructured":"Li W, Guentzel MN, Seshu J, Zhong G, Murthy AK, Arulanandam BP. Induction of cross-serovar protection against genital chlamydial infection by a targeted multisubunit vaccination approach. Clin Vaccine Immunol 14(12): 1537-44","DOI":"10.1128\/CVI.00274-07"},{"issue":"4","key":"10.1016\/j.vaccine.2017.05.063_b0210","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/mi.2015.125","article-title":"Induction of partial immunity in both males and females is sufficient to protect females against sexual transmission of Chlamydia","volume":"9","author":"O'Meara","year":"2016","journal-title":"Mucosal Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17307223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17307223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T23:42:26Z","timestamp":1692834146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17307223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":42,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0264410X17307223"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.05.063","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multistage vaccines containing outer membrane, type III secretion system and inclusion membrane proteins protects against a Chlamydia genital tract infection and pathology","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.05.063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}